SEC Form 4 · accession 0001437749-17-004936
BIO KEY INTERNATIONAL INC · BKYI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Michael W Depasquale
Officer — Pres., CEO & Director · Director
Period of report
Mar 16, 2017
Accepted (ET)
Mar 20, 2017 · 4:52 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001019034
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy)F1 | $2.65 | Mar 16, 2017 | A | 250,000 | A | — | Mar 15, 2024 | Common Stock | 250,000 | 250,000 | D |
Explanation of responses
- F1The option vests in three equal annual installments on March 16, 2018, 2019 and 2020.